DaVita
Prezzo: 208.66Società e modello di business
DaVita Inc. operates in the healthcare sector, primarily providing kidney care and dialysis services. The company offers a range of services including in-center hemodialysis, home dialysis, and related laboratory services. Its major business segments include dialysis services and ancillary services, with the majority of revenue generated from patient services in its dialysis centers. DaVita serves a diverse patient population across the United States and has a growing presence in international markets.
Profilo di investimento
The investment profile of DaVita is more aligned with growth investors, given its focus on expanding services and improving patient care. The company has shown potential for revenue growth despite recent fluctuations. It may appeal to investors looking for a balanced approach, considering its operational stability and market position.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 10.15 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- -5.6% ↓
- Sorpresa EPS
- 23.2% meglio del previsto
- Volatilità 20g
- 1.9% stabile
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-10 00:47 | Mantieni | Compra | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-06-01 02:36 | Compra | Mantieni | Strong momentum but recent revenue decline raises concerns. |
| 2026-05-16 02:40 | Mantieni | Compra | Strong momentum and positive EPS surprise support bullish outlook. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-05-08 11:56 | Truist Financial | Target alzato | 158 → 205 | 194.385 |
| 2026-05-07 09:46 | Barclays | Target alzato | 158 → 194 | 193.88 |
| 2026-05-06 08:37 | Deutsche Bank | Rating migliorato | — → 220 | 157.04 |
Ancora nulla